Because MMP-1 and MMP-3 are produced abundantly by the synovial lining layer and are known to play a key role in the progressive joint damage that occurs in RA (17, 18), we focused on these two molecules as potential biomarkers for classifying the early inflamed synovium (Figure 1). The gene discussed is MMP3; the disease is rheumatoid arthritis.